Notice of Interim Results

RNS Number : 1275S

C4X Discovery Holdings PLC

15 March 2016

 

C4X Discovery Holdings plc

("C4XD" or the "Company")

Notice of Interim Results

15 March, 2016 - C4X Discovery Holdings plc (AIM: C4XD), an innovative drug discovery and development company, will be announcing its interim results for the six months ended 31 January 2016 on Thursday 17 March 2016. 

--ENDS--

For further information please contact:

C4X Discovery Holdings plc

Clive Dix, Executive Chairman                                                                                   07801 865803

Zeus Capital

Dan Bate                                                                                                                              0161 393 1973

Dominic Wilson/Phil Walker                                                                                      0203 829 5000

Consilium Strategic Communications

Mary-Jane Elliott, Chris Gardner, Matthew Neal, Chris Welsh                     0203 709 5700

About C4X Discovery

C4X Discovery aims to become the world's most productive drug discovery and development company by exploiting cutting-edge technologies to design and create best-in-class drug candidates. The Company has two proprietary and synergistic software platforms "Taxonomy3®" and "Conformetrix" that provide a significant competitive advantage when combined with an experienced management team. "Taxonomy3®" is a human genetics analysis platform that utilises a unique mathematical approach to discovery and validation of drug targets for the treatment of a variety of diseases. "Conformetrix" determines the 3D shape of drug molecules from experimental in vitro data that enables the rapid design and discovery of novel and potent drugs for diseases with high unmet medical need across broad therapeutic areas. We have a hybrid business model of wholly-owned programmes and partnerships with pharma, biotech and academics.

The Company was founded in 2008 as a spin-out from the University of Manchester and has a highly experienced management team and Board who have delivered significant value creation within the healthcare sector historically. For additional information please go to: www.c4xdiscovery.com

 

END

 

 

NORGGUPAWUPQUBA